Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMelodiol Global Health Ltd.

Melodiol Global Health Ltd.

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None AUD 0.00(0%)
Last update at 2024-12-10T00:00:14.191264Z
Market Cap
1.13M

Momentum Score

…

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.00
Low
1.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
18.92M
Revenue Per Share
4.07
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-389.56%
Net Debt
-
ROCE
-144.64%
Diluted EPS TTM
-7.64

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Income before tax -32.78M -30.03M -30.78M
Net income -32.78M -30.03M -30.78M
Selling general administrative 16.67M 26.98M 9.71M
Gross profit 0.37M - 0.14M
Operating income -32.24M -30.03M -30.78M
Interest expense - 0.52M 4.93M
Tax provision 0.00M 0.00M 0.00M
Interest income 0.38M - -
Total revenue 8.77M 6.22M 2.45M
Cost of revenue 8.40M - 2.30M
Net income applicable to common shares -32.78M -30.03M -30.78M
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Total assets 37.98M 29.31M 19.12M
Intangible assets 15.85M 8.31M 1.28M
Other current assets - 0.46M 0.14M
Total liab 15.69M 1.56M 5.47M
Total stockholder equity 22.29M 27.76M 13.65M
Common stock 128.38M 109.95M 71.79M
Retained earnings -109.00M -83.57M -58.44M
Other assets 0.29M 0.42M -
Cash and equivalents 1.39M 7.18M 6.05M
Total current liabilities 15.69M 1.56M 5.47M
Short term debt 0.00M 0.00M 3.26M
Other stockholder equity 2.91M 1.38M 0.30M
Property plant equipment 9.98M 10.44M 9.91M
Total current assets 11.87M 10.14M 7.94M
Net receivables 1.89M 1.10M 0.64M
Inventory 5.77M 1.40M 1.11M
Long term debt total 0.00M 0.00M 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31
Total cashflows from investing activities -2.28M -1.37M -0.83M
Total cash from financing activities 13.81M 24.89M 13.65M
Change in cash -5.80M 1.14M 3.25M
Total cash from operating activities -17.31M -22.38M -9.62M
Other cashflows from investing activities -1.94M -0.92M -0.40M
Sale purchase of stock 9.34M 25.09M 10.75M
Other cashflows from financing activities -0.12M 0.00M -2.19M
Capital expenditures 0.35M 0.45M 0.43M
Change in working capital -0.42M 0.00M 0.00M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AFP
Aft Pharmaceuticals Ltd		 0.05
1.41%		 3.60 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd		 0.09
3.42%		 2.72 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd		 0.01
16.67%		 0.07 - 10.00 0.64 0.60 1.25 19.47
MVP
Medical Developments International Ltd		 -
-%		 0.44 40.00 166.67 1.06 0.79 0.57 7.45

Profile*

Melodiol Global Health Ltd.

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

145 Stirling Highway, Nedlands, WA, Australia, 6009

61 8 9389 3180

https://melodiolglobalhealth.com

Name Title Year Born
Mr. Boaz Wachtel M.A., M.D., MBA Co-Founder & Non-Executive Chairman 1960
Mr. William Lay B.Com. Group CEO, MD & Director NA
Mr. Christopher Grundy BCom, FCA, FCIS, GAICD Chief Financial Officer NA
Ms. Micheline MacKay B.Sc., M.Sc., P.M.P. Executive Director NA
Ms. Jodi Scott M.Sc. Executive Director NA
Dr. Gian Trepp Commercial & Marketing Director NA
Mr. Mitchel Fleming Managing Director of Halucenex NA
Brett Ayers Managing Director of Impactive NA
Mr. Winton William Willesee C.P.A., GAICD, MAICD, MCom Joint Company Secretary 1970
Hon. Brian Walker Strategic Consultant & Chair of Scientific Advisory Committee NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…